HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hagit Dafni Selected Research

Collagen Type I (Type I Collagen)

9/2003Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hagit Dafni Research Topics

Disease

17Neoplasms (Cancer)
10/2016 - 04/2002
6Neoplasm Metastasis (Metastasis)
10/2016 - 03/2005
3Carcinoma (Carcinomatosis)
10/2016 - 11/2005
2Ovarian Neoplasms (Ovarian Cancer)
10/2016 - 11/2005
2Prostatic Neoplasms (Prostate Cancer)
06/2012 - 10/2008
2Hypoxia (Hypoxemia)
10/2010 - 02/2010
2Breast Neoplasms (Breast Cancer)
02/2010 - 04/2003
2Lymphatic Metastasis
03/2005 - 11/2002
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2016
1Carcinogenesis
06/2012
1Glioblastoma (Glioblastoma Multiforme)
02/2010
1Ovarian Epithelial Carcinoma
11/2005
1Lymphoma (Lymphomas)
03/2005
1Human Influenza (Influenza)
02/2005
1Glioma (Gliomas)
02/2005
1Edema (Dropsy)
02/2004
1Pheochromocytoma
09/2003
1Infertility (Sterility)
06/2003
1Fibrosis (Cirrhosis)
04/2003

Drug/Important Bio-Agent (IBA)

6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2010 - 04/2002
4Contrast MediaIBA
11/2016 - 11/2002
2Imatinib Mesylate (Gleevec)FDA Link
06/2012 - 10/2010
2Pyruvic Acid (Pyruvate)IBA
10/2010 - 02/2010
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2010 - 10/2008
2Lactic Acid (Lactate)FDA LinkGeneric
10/2010 - 02/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2005 - 04/2002
2enhanced green fluorescent proteinIBA
03/2005 - 02/2005
1AlbuminsIBA
11/2016
1Serum AlbuminIBA
11/2016
13- (5- methyl- 2- (2- oxo- 1,2- dihydroindol- 3- ylidenemethyl)- 1H- pyrrol- 3- yl)propionic acidIBA
06/2012
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2010
1GlutaminaseIBA
10/2010
1Proteins (Proteins, Gene)FDA Link
02/2010
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
02/2010
1EverolimusFDA Link
02/2010
1Messenger RNA (mRNA)IBA
02/2010
1Biomarkers (Surrogate Marker)IBA
01/2010
1diethylenetriamineIBA
10/2008
1AcidsIBA
10/2008
1Biotin (Vitamin H)FDA Link
10/2008
1Bovine Serum AlbuminIBA
10/2008
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2008
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
11/2005
1Hyaluronic Acid (Hyaluronan)IBA
11/2005
1AngiopoietinsIBA
11/2005
1Angiopoietin-1IBA
11/2005
1heparanaseIBA
03/2005
1Hemagglutinins (Hemagglutinin)IBA
02/2005
1Ferritins (Ferritin)IBA
02/2005
1Tetracycline (Achromycin)FDA LinkGeneric
02/2005
1Blood Proteins (Serum Proteins)IBA
02/2004
1AvidinIBA
11/2003
1halofuginoneIBA
09/2003
1GelatinasesIBA
09/2003
1Cytostatic AgentsIBA
09/2003
1Pharmaceutical PreparationsIBA
09/2003
1Matrix Metalloproteinases (MMPs)IBA
09/2003
1Collagen Type I (Type I Collagen)IBA
09/2003
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
04/2003
1EnzymesIBA
04/2003
1CollagenIBA
04/2003
1Estrogens (Estrogen)FDA Link
04/2003

Therapy/Procedure

5Therapeutics
10/2016 - 04/2002
1Drug Therapy (Chemotherapy)
10/2016
1Transplantation
01/2016
1Aftercare (After-Treatment)
02/2010
1Intraperitoneal Injections
03/2008
1Radiotherapy
06/2003